Integrated Regional Laboratories Pathology Services, LLC
Integrated Regional Laboratories Pathology Services, LLC was paid $115K by Medicaid between Mar 2021 and Nov 2024, across 41 billing codes. Its largest line is 87275, — 23% of everything it billed.
OKEECHOBEE, FL 34972
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 3,074 | $4K | |
| 2022 | 8,756 | $25K | |
| 2023 | 22,052 | $65K | |
| 2024incomplete | 19,163 | $21K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87275 | 23% | 3,224 | 3,021 | $26K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 18% | 669 | 628 | $21K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 10% | 593 | 470 | $12K |
| 87040 | 8.2% | 1,215 | 1,047 | $9K | |
| 80053 | Comprehensive metabolic panel | 5.6% | 3,885 | 2,995 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.2% | 4,243 | 1,986 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.1% | 1,308 | 1,225 | $6K |
| 81025 | 2.6% | 1,864 | 1,645 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 2,447 | 2,289 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.4% | 29 | 27 | $3K |
| 85027 | 2.4% | 7,120 | 4,343 | $3K | |
| 84484 | 2.2% | 2,173 | 1,516 | $2K |
29 more codes
| 87276 | 1.8% | 3,231 | $2K | |
| 83735 | 1.7% | 4,508 | $2K | |
| 83605 | 1.6% | 1,169 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 334 | $2K |
| 87807 | <1% | 1,269 | $1K | |
| 87070 | <1% | 2,326 | $1K | |
| 83690 | <1% | 1,964 | $833.59 | |
| 83880 | <1% | 414 | $691.75 | |
| 81001 | <1% | 2,412 | $629.08 | |
| 80076 | <1% | 1,540 | $586.89 | |
| 85730 | <1% | 1,216 | $463.39 | |
| 87088 | <1% | 281 | $321.72 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 142 | $289.14 |
| 85610 | <1% | 1,270 | $286.21 | |
| 81003 | <1% | 1,175 | $225.83 | |
| 85379 | <1% | 385 | $195.15 | |
| 82805 | <1% | 29 | $192.79 | |
| 80320 | <1% | 80 | $184.42 | |
| 84702 | <1% | 72 | $133.00 | |
| 84703 | <1% | 26 | $45.71 | |
| 80061 | Lipid panel | <1% | 38 | $39.59 |
| 86850 | <1% | 31 | $27.76 | |
| 86900 | <1% | 106 | $25.91 | |
| 86901 | <1% | 106 | $25.91 | |
| 84100 | <1% | 65 | $15.93 | |
| 86140 | <1% | 42 | $6.48 | |
| 82550 | <1% | 13 | $5.25 | |
| 85651 | <1% | 18 | $0.57 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.